Treating urine infections is becoming increasingly challenging due to rising antibiotic resistance. Here's what's driving ...

A groundbreaking antibiotic discovery might finally tip the balance in the global fight against drug-resistant bacteria.

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

London: Israeli researchers have found dangerous, antibiotic-resistant Vibrio bacteria in the Mediterranean and Red Seas, ...

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm ...

Experts at the University of Dundee have announced promising results from a clinical trial of a potential new antibody ...

Armata Pharmaceuticals has posted early validation of its phage platform. The phase 1b/2a trial linked a bacteriophage ...

“Antibiotics are designed to combat bacterial infections, not viral ones like the common cold,” explains Asif. “Since colds ...